Passage Bio PASG
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 11.80 | 109.13 | -4.09 | -10,340 | -13 | |
| 2025Q3 | 8.03 | 111.69 | -2.43 | -8,655 | -8 | |
| 2025Q2 | 8.01 | 110.11 | -2.83 | -10,334 | -9 | |
| 2025Q1 | 7.06 | 106.84 | -5.00 | -16,459 | -15 | |
| 2024Q4 | 11.34 | 112.14 | -4.00 | -14,270 | -13 | |
| 2024Q3 | 14.00 | 107.04 | -6.17 | -20,702 | -19 | |
| 2024Q2 | 15.88 | 108.67 | -4.87 | -17,378 | -16 | |
| 2024Q1 | 27.00 | 108.01 | -6.00 | -18,050 | -17 | |
| 2023Q4 | 20.20 | 110.07 | -6.00 | -18,446 | -17 | |
| 2023Q3 | 13.16 | 105.76 | -10.00 | -28,672 | -27 | |
| 2023Q2 | 18.83 | 106.42 | -8.60 | -25,388 | -24 | |
| 2023Q1 | 19.15 | 104.50 | -12.60 | -35,883 | -34 | |
| 2022Q4 | 27.60 | 104.33 | -9.80 | -28,244 | -27 | |
| 2022Q3 | 25.00 | 103.09 | -9.80 | -27,526 | -27 | |
| 2022Q2 | 47.20 | 100.68 | -14.60 | -39,812 | -40 | |
| 2022Q1 | 62.00 | 100.00 | -15.80 | -42,812 | -43 | |
| 2021Q4 | 127.00 | 100.01 | -19.00 | -51,160 | -51 | |
| 2021Q3 | 199.20 | 100.40 | -17.40 | -47,101 | -47 | |
| 2021Q2 | 264.80 | 100.20 | -18.00 | -48,534 | -48 | |
| 2021Q1 | 349.60 | 100.13 | -15.20 | -38,934 | -39 |